Physical Activity Adapted at Home Supervised by Videoconferencing in Post-cancer for Children / AYA Treated for Leukemia (ONCOPED SAPATIC)

NCT04136665 | Terminated

• 1 other identifier: RECHMPL19_0181
• Study Type: interventional
• Target: 2
• Locations: 1 country
• Sites: 1

Brief Summary

Leukemia is the most common form of cancer (29%) in children, adolescents, and young adults (AYA) (CNIB Report, 2017). Current treatments for leukemia (conventional chemotherapy or hematopoietic stem cell transplantation) can lead to significant side effects, acute or chronic, which can lead to impaired physical abilities and reduced quality of life for patients in short, medium or long term. For children and AYA with cancer, adapted physical activity (APA) is now recommended even if the scientific evidence of its benefit is still insufficient.

Conditions

Leukemia

Keywords

children; leukemia; physical activity adapted

Outcome Measures

Primary Outcomes (1)

• evaluate the feasibility of a 6-month APA home program, supervised by videoconferencing in post-cancer for children / AYA treated for leukemia: number of completed session / number of theorical session

  Assessment of the feasibility of a 6-month APA home program, supervised by videoconferencing in post-cancer for children / AYA treated for leukemia : number of completed session / number of theorical session

  6 months

Secondary Outcomes (4)

• evaluate the impact of a 6-month APA home program on the muscle strength of lower limbs

  6 months

• evaluate the impact of a 6-month APA home program on the exercise capacity

  6 months

• evaluate the impact of a 6-month APA home program on the muscle flexibility

  6 months

• evaluate the impact of a 6-month APA home program on the quality of life: PedsQL

  6 months

Study Arms (1)

Physical Activity Adapted program

EXPERIMENTAL

Other: Physical Activity Adapted program

Interventions

Physical Activity Adapted program OTHER

6-month APA home program, supervised by videoconferencing in post-cancer for children / AYA treated for leukemia

Physical Activity Adapted program

Eligibility Criteria

• Age: 12 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Patient with Leukemia and followed in intensive post-treatment or with lymphoma and followed in post autologous graft, patient aged 12 to 25 years old (child/AYA), included in the CHU Montpellier and identified by the mobile support team AYA Occitanie-Est, and or the Occitanie-Est Pediatric Division of the Oncology Network of the Occitanie Region,
• Having completed and signed a consent form for the study (Signature of consent by the parents if the patient is a minor)
• affiliated to a safety social regime

You may not qualify if:

• Contraindication to the practice of an APA program.

Sponsors & Collaborators

• University Hospital, Montpellier: lead
• mooven society: collaborator

Study Sites (1)

CHU de Montpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Leukemia

Condition Hierarchy (Ancestors)

Neoplasms by Histologic Type; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 18, 2019
• First Posted: October 23, 2019
• Study Start: December 14, 2019
• Primary Completion: September 6, 2022
• Study Completion: September 6, 2022
• Last Updated: December 22, 2022

Record last verified: 2022-01

Locations

FR (1)